Boston Scientific launches new devices in Europe

Boston Scientific Corp. announced today the first European implants of new devices to treat heart failure and sudden cardiac arrest.

The Natick medical device maker said that doctors began performing implants of its Cognis cardiac resynchronization therapy defibrillator and its Teligen implantable cardioverter defibrillator.

The implants represent the beginning of the products' market launch in Europe, and the company said it plans to "build to a full launch in Europe and other international markets in the second quarter."

The devices are pending approval by the US Food and Drug Administration, Boston Scientific said.
(By Chris Reidy, Globe staff)